Libo Pharma Corp.
PrivateLast Round
Series C
Jul 21, 2025
Total Funding Raised
$29.33M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Libo Pharma Corp. operates in Healthcare & Life Sciences and is based in Taipei. Its latest recorded funding round was a Series C round in July 2025.
Libo Pharma Corp. is a biotechnology company that operates as a biopharmaceutical innovation incubator developing novel protein therapeutics and immunotherapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Libo Pharma Corp. Comparables
Compare Libo Pharma Corp. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Statera BioPharma, Inc. | 76% | |
| Partner Therapeutics | 74% | |
| PharmaEngine, Inc. | 71% |
For institutional investors. Book with your work email.
Libo Pharma Corp. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jul 21, 2025 | ||||
| Series B | Mar 1, 2024 | ||||
| Seed | Jun 1, 2017 |
For institutional investors. Book with your work email.
Libo Pharma Corp. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CTBC Venture Capital | Series C |
| Beiley Biofund | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 160% MoM, reaching 1.9K.
- Jul 27, 2026
Grew 29% QoQ, from 14 to 18 employees.
For institutional investors. Book with your work email.
Libo Pharma Corp. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Libo Pharma Corp.'s valuation, stock price, and market status.
Is Libo Pharma Corp. a public or private company?
Libo Pharma Corp. is a private company.
What is the current stock price of Libo Pharma Corp.?
Libo Pharma Corp. is a private company, so its shares have no public market price. Caplight tracks Libo Pharma Corp.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Libo Pharma Corp. worth (valuation)?
Valuation information for Libo Pharma Corp. is not publicly available.
Can I buy Libo Pharma Corp. stock?
Libo Pharma Corp. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Libo Pharma Corp.'s last funding round?
Libo Pharma Corp.'s most recent funding round was Series C on July 21, 2025.
Who are the main investors in Libo Pharma Corp.?
Key investors in Libo Pharma Corp. include CTBC Venture Capital, Beiley Biofund.
Will Libo Pharma Corp. IPO soon?
No public IPO plans have been announced for Libo Pharma Corp..
How can I track Libo Pharma Corp. secondary market activity?
Caplight tracks bids, offers, and trades in Libo Pharma Corp.'s shares on secondary markets.